Your browser doesn't support javascript.
loading
Wound Infections in Adult Patients after Berlin Heart® EXCOR Biventricular Assist Device Implantation.
Kremer, Jamila; El-Dor, Abbas; Rivinius, Rasmus; Schlegel, Philipp; Sommer, Wiebke; Warnecke, Gregor; Karck, Matthias; Ruhparwar, Arjang; Meyer, Anna L.
Afiliación
  • Kremer J; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • El-Dor A; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Rivinius R; Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Schlegel P; Department of Cardiology, Angiology and Pneumology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
  • Sommer W; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Warnecke G; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Karck M; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Ruhparwar A; Clinic of Thoracic and Cardiovascular Surgery, Essen University Hospital, 45147 Essen, Germany.
  • Meyer AL; Department of Cardiothoracic Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Life (Basel) ; 12(10)2022 Oct 06.
Article en En | MEDLINE | ID: mdl-36294985
The Berlin Heart® EXCOR is a paracorporeal, pulsatile ventricular assist device used in patients of all age groups. However, adolescent and adult patients on EXCOR support are scarcely explored. Herein, we present a detailed description of infectious complications in this patient cohort. From 2006 to 2020, 58 patients received a biventricular assist device (BiVAD) at our institution and were included in this study. Postoperative infections were assessed after BiVAD implantation and subsequent heart transplantation (HTx). A Berlin Heart® EXCOR BiVAD was implanted as a bridge to transplantation in 58 patients (12-64 years). Most patients were INTERMACS I, and their median age was 49 years. Wound infections (WI) specific to the ventricular assist device (VAD) occurred in 31 (53.4%) patients with a mean time of 113 ± 155 days after BiVAD implantation. HTx was performed in 30 (51.7%) patients and thereof 10 (33.3%) patients developed at least one WI post-HTx. The mean time of WI after HTx was 17 ± 14 days. In four cases, WIs were caused by the same pathogen as before HTx. According to our institutional BiVAD wound classification, the mean wound score was 3. The VAD-specific wound infections were manageable and did not increase mortality nor precluded HTx in Berlin Heart® EXCOR patients. No specific risk factors for VAD-specific wound infections could be identified.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Life (Basel) Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza